![Stéphane Boissel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stéphane Boissel
Direktor/Vorstandsmitglied bei
ADOCIA
Profil
Stéphane Boissel currently works at SparingVision SAS, as President, Chief Executive Officer & Director from 2023, Cottages Participations SAS, as Chairman, Adocia SA, as Independent Director from 2021, Transgene, Inc., as Director, Platine Pharma Services SAS, as Director, Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd., as Director, EG 427 SAS, as Director from 2021, and The French Society of Financial Analysts, as Member.
Mr. Boissel also formerly worked at Sangamo Therapeutics France SAS, as Chief Executive Officer, Genclis SA, as Chief Executive Officer from 2014 to 2015, ElsaLys Biotech SAS, as Non-Executive Chairman from 2013 to 2018, ERYTech Pharma SA, as Director from 2004 to 2009, Pharmaxon SAS, as Director, Sangamo Therapeutics, Inc., as Executive Vice President-Corporate Strategy from 2019 to 2020, Eurazeo SE, as Vice President from 1995 to 1998, Transgene SA, as Chief Financial Officer & Executive Vice President from 2010 to 2014, Innate Pharma SA, as Chief Financial Officer & Executive Vice President in 2010, Lazard Group LLC, as Vice President in 2002, France Biotech Association, as Member, PricewaterhouseCoopers France SARL, as Auditor in 1994, and Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd., as Member-Supervisory Board.
Mr. Boissel received his graduate degree in 1993 from Université Paris Dauphine-PSL, undergraduate degree from the University of Lyon, and Masters Business Admin degree from The University of Chicago Booth School of Business.
Aktive Positionen von Stéphane Boissel
| Unternehmen | Position | Beginn |
|---|---|---|
| ADOCIA | Direktor/Vorstandsmitglied | 21.05.2021 |
SparingVision SAS
 SparingVision SAS BiotechnologyHealth Technology Develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa | Vorstandsvorsitzender | 21.10.2020 |
Cottages Participations SAS
 Cottages Participations SAS MiscellaneousMiscellaneous Operates as a non-classified establishment | Vorsitzender | - |
The French Society of Financial Analysts
 The French Society of Financial Analysts Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd. | Direktor/Vorstandsmitglied | - |
Transgene, Inc.
 Transgene, Inc. Founded in 1982, Transgene, Inc. is a clinical-stage biotechnology company specializing in cancer immunotherapy through viral vector engineering. The company is based in Dover, DE. The company develops individualized therapeutic vaccines using its proprietary myvac® platform, which designs personalized vaccines targeting tumor-specific neoantigens to stimulate the patient’s immune system against early-stage solid tumors. Its lead product, TG4050, is an individualized neoantigen vaccine in randomized phase 1/2 trials as an adjuvant treatment for HPV-negative head and neck squamous cell carcinoma. Transgene’s pipeline also includes oncolytic virus candidates BT-001 and TG6050, engineered to express immune-modulating antibodies and cytokines, evaluated in early-phase clinical trials for various solid tumors. | Direktor/Vorstandsmitglied | - |
Platine Pharma Services SAS
 Platine Pharma Services SAS Medical/Nursing ServicesHealth Services Provides immune-monitoring services | Direktor/Vorstandsmitglied | - |
Genelpis SAS
 Genelpis SAS BiotechnologyHealth Technology Operates as a biotechnology company that develops pinpoint DNA medicines for chronic diseases | Direktor/Vorstandsmitglied | 01.03.2021 |
Ehemalige bekannte Positionen von Stéphane Boissel
| Unternehmen | Position | Ende |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Finanzdirektor/CFO | 31.10.2019 |
| ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Stéphane Boissel
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
68
Beziehungen ersten Grades
24
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 24 |
|---|---|
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Eurazeo SE
 Eurazeo SE Investment ManagersFinance Functions as an private equity company | Finance |
Transgene SA
 Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
Innate Pharma SA
 Innate Pharma SA Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies that harness the immune system to improve cancer treatment and clinical outcomes | Health Technology |
Lazard Group LLC
 Lazard Group LLC Investment ManagersFinance Provides financial advisory, asset management and investment services | Finance |
Université Paris Dauphine-PSL
 Université Paris Dauphine-PSL Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ERYTech Pharma SA
 ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology Develops medicinal products for orphan oncology and rare diseases | Health Technology |
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services Operates an organisation for growth of health industry | Commercial Services |
University of Lyon
 University of Lyon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sangamo Therapeutics France SAS
 Sangamo Therapeutics France SAS BiotechnologyHealth Technology Develops cellular immunotherapy platforms that treats severe inflammatory and autoimmune diseases | Health Technology |
Pharmaxon SAS
 Pharmaxon SAS Pharmaceuticals: MajorHealth Technology Discovers, develops and markets therapeutic drugs controlling cell mobility | Health Technology |
Genclis SA
 Genclis SA Miscellaneous Commercial ServicesCommercial Services Operates as a holding company with interest in providing research services to the medical and biotechnology firms | Commercial Services |
Adocia SA
 Adocia SA Pharmaceuticals: MajorHealth Technology Manufactures novel therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases | Health Technology |
The French Society of Financial Analysts
The French Society of Financial Analysts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PricewaterhouseCoopers France SARL
 PricewaterhouseCoopers France SARL Miscellaneous Commercial ServicesCommercial Services Provides auditing, legal, tax and consulting services | Commercial Services |
Transgene, Inc.
Transgene, Inc. Founded in 1982, Transgene, Inc. is a clinical-stage biotechnology company specializing in cancer immunotherapy through viral vector engineering. The company is based in Dover, DE. The company develops individualized therapeutic vaccines using its proprietary myvac® platform, which designs personalized vaccines targeting tumor-specific neoantigens to stimulate the patient’s immune system against early-stage solid tumors. Its lead product, TG4050, is an individualized neoantigen vaccine in randomized phase 1/2 trials as an adjuvant treatment for HPV-negative head and neck squamous cell carcinoma. Transgene’s pipeline also includes oncolytic virus candidates BT-001 and TG6050, engineered to express immune-modulating antibodies and cytokines, evaluated in early-phase clinical trials for various solid tumors. | |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Platine Pharma Services SAS
Platine Pharma Services SAS Medical/Nursing ServicesHealth Services Provides immune-monitoring services | Health Services |
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd.
 Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Researches, develops and manufactures immunotherapies for the treatment of oncology and infectious diseases | Commercial Services |
ElsaLys Biotech SAS
 ElsaLys Biotech SAS Pharmaceuticals: MajorHealth Technology Designs, develops and supplies antibodies to modulate the immune system of patients | Health Technology |
Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd. | |
SparingVision SAS
SparingVision SAS BiotechnologyHealth Technology Develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa | Health Technology |
Cottages Participations SAS
Cottages Participations SAS MiscellaneousMiscellaneous Operates as a non-classified establishment | Miscellaneous |
Genelpis SAS
Genelpis SAS BiotechnologyHealth Technology Operates as a biotechnology company that develops pinpoint DNA medicines for chronic diseases | Health Technology |
